Press release
Air Pollution And Climate Change Fueling Growth In The Allergic Rhinitis Market: The Driving Engine Behind Allergic Rhinitis Market Evolution in 2025
Allergic Rhinitis
Allergic Rhinitis Market Size Growth Forecast: What to Expect by 2025?
In the past few years, a consistent growth has been observed in the allergic rhinitis market size. The market which is projected to surge from $15.22 billion in 2024 to $15.74 billion in 2025, suggests a compound annual growth rate (CAGR) of 3.4%. Factors such as exposure to allergens, environmental modifications, public awareness, escalating pollution, research and advancements on allergic rhinitis, along with an increase in disposable income have contributed to the historic period growth.
How Will the Allergic Rhinitis Market Size Evolve and Grow by 2029?
The market size for allergic rhinitis is projected to undergo consistent expansion in the forthcoming years. The anticipated growth will propel it to $18.49 billion by 2029, resulting in a Compound Annual Growth Rate (CAGR) of 4.1%. The predicted growth can be credited to an increased need for preventive measures, a rising elderly populace, urbanization, and health care expenditures. Upcoming trends for this period involve biologics and monoclonal antibodies, allergen detection technology, pediatric allergic rhinitis, allergen avoidance approaches, and digital health solutions.
View the full report here:
https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report
What Drivers Are Propelling the Growth of Allergic Rhinitis Market Forward?
The rise in air pollution and climate change are anticipated to drive the progress of the allergic rhinitis market. Air pollution, which involves harmful substances in the Earth's atmosphere, can negatively impact human health, environmental conditions, and the quality of our breathable air. Climate change is a term referring to long-term changes in weather patterns, such as changes in temperature, precipitation, and other weather-related factors. The role of air pollution as a significant environmental condition that contributes to the incidence and worsening of allergic rhinitis is increasingly being understood, revealing the complex link between air quality and respiratory health. For example, the United States Environmental Protection Agency, a US government agency, reported in August 2024 that around 66 million tons of pollutants were discharged into the atmospheric environment throughout the United States in 2023. Hence, high air pollution levels and climate change continue to directly impact the allergic rhinitis market. The expanding use of corticosteroid treatment for allergic rhinitis is predicted to boost the allergic rhinitis market forward. This treatment approach, often referred to as steroid treatment, utilizes medications known as corticosteroids or simply steroids. They are frequently employed in treating allergic rhinitis as they aid in decreasing inflammation in the nasal passages and help mitigate the symptoms of the disease. For example, in September 2023, the American Society for Clinical Pharmacology and Therapeutics, a professional organization based in the United States, recorded an average usage of oral corticosteroids of 6.8% in the U.S., 17.5% in Taiwan, and 2.2% in Denmark, with annual increases ranging from 0.1% to 0.17%. These prescriptions were predominantly short-lived (1-29 days) and were prescribed for otherwise healthy adults suffering from self-limited conditions like respiratory infections. Consequently, the rise in corticosteroid treatments for allergic rhinitis stimulates the growth of the allergic rhinitis market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12926&type=smp
Which Emerging Trends Are Transforming the Allergic Rhinitis Market in 2025?
Top corporations in the allergic rhinitis market are focusing on the creation of innovative drugs to maintain their market dominance. For instance, in August 2022, UK's Hikma Pharmaceuticals PLC and Switzerland's Glenmark Specialty S.A. received approval from the United States Food and Drug Administration (FDA) for their product Ryaltris. This is the first combined-dose drug made available in a handy nasal spray that addresses both nasal and eye symptoms of seasonal allergic rhinitis in adults and children aged 12 and above. Remarkably, the relief from nasal symptoms begins within 15 minutes of administering the first dose.
What Are the Key Segments in the Allergic Rhinitis Market?
The allergic rhinitis market covered in this report is segmented -
1) By Type: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis
2) By Treatment: Antihistamines, Corticosteroids, Immunotherapy, Decongestants, Other Treatments
3) By Test: Skin Test, IgE Radioallergosorbent (RAST) Test, Complete Blood Count
4) By Route Of Administration: Oral, Nasal, Other Route Of Administration
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores
Subsegments:
1) By Seasonal Allergic Rhinitis: Pollen Allergy, Mold Allergy
2) By Perennial Allergic Rhinitis: Dust Mite Allergy, Pet Allergy, Mold Allergy
3) By Occupational Allergic Rhinitis: Chemical Allergens, Biological Allergens
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12926&type=smp
Who Are the Key Players Shaping the Allergic Rhinitis Market's Competitive Landscape?
Major companies operating in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd., Akorn Inc.
What Geographic Markets Are Powering Growth in the Allergic Rhinitis Market?
North America was the largest region in the allergic rhinitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12926
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Air Pollution And Climate Change Fueling Growth In The Allergic Rhinitis Market: The Driving Engine Behind Allergic Rhinitis Market Evolution in 2025 here
News-ID: 4118624 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Allergic
Prominent Allergic Rhinitis Market Trend for 2025: Advancements In Treating Nasa …
Which drivers are expected to have the greatest impact on the over the allergic rhinitis market's growth?
Anticipated growth in the allergic rhinitis market is predicted to be driven by increasing levels of air pollution and the impact of climate change. The term air pollution denotes the existence of harmful substances in our planet's atmosphere, which can negatively impact human health, damage the environment, and reduce the air's quality. Climate change…
Allergic Rhinitis: A Comprehensive Overview
Allergic rhinitis, commonly known as hay fever, is a condition where an individual's immune system overreacts to allergens in the air. These allergens, which may include pollen, dust, or pet dander, trigger inflammation inside the nose, leading to symptoms like sneezing, a runny nose, itchy eyes, and congestion. While often associated with the spring and fall seasons due to pollen levels, allergic rhinitis can affect individuals year-round, depending on the…
Allergic Conjunctivitis Market Statistics, Growth | Forecast
The new report published by The Business Research Company, titled ""Allergy Conjunctivitis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the allergy conjunctivitis market size has grown strongly in recent years. It will grow from $2.4 billion in 2023…
Anti-Allergic Drugs Market Overview 2030
Anti-allergic drugs represent a pivotal domain in healthcare, providing advanced solutions to alleviate symptoms triggered by allergens. With an ever-growing prevalence of allergies globally, the anti-allergic drugs market is witnessing a significant surge. Valued at USD 26,234 Million in 2021, the market is poised to skyrocket to USD 47,566 Million by 2030, showcasing a robust CAGR of 6.8%. In the United States alone, where allergies affect 40 to 50 million…
Allergic Conjunctivitis Market - Clear Eyes, Allergy-Free: Allergic Conjunctivit …
Newark, New Castle, USA: The "Allergic Conjunctivitis Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Allergic Conjunctivitis Market: https://www.growthplusreports.com/report/allergic-conjunctivitis-market/7892
This latest report researches the industry structure, sales, revenue,…
Allergic Conjunctivitis Market - Empowering Eyes, Enhancing Lives: Redefining Al …
Newark, New Castle, USA - new report, titled Allergic Conjunctivitis Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Allergic Conjunctivitis market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Allergic Conjunctivitis market. The report offers an overview of the market, which…
